Initiative will fast-track vaccine for childhood diarrhoea in developing world
A $30m (£18m; €28m) three year project to accelerate the development of a safe and effective rotavirus vaccine for the developing world was announced this week by the Global Alliance for Vaccines and Immunisations and the Vaccine Fund.
The project will be led by the Program for Appropriate Technology in Health, an international organisation that aims to improve the health of women and children. The programme's team will include public health experts from the World Health Organization, the Centers for Disease Control and Prevention, and the Children's Vaccine Program.
Rotavirus is the leading cause of severe diarrhoea and deaths related to diarrhoea. Virtually all children, no matter where they live in the world, will contract rotavirus diarrhoea before the age of 5 years.
Whereas a child with rotavirus infection in Europe may have diarrhoea and vomiting--and in severe cases would need to be admitted to hospital--a child with rotavirus infection